These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 10037009

  • 1. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma.
    Gale RP, Park RE, Dubois R, Bierman PJ, Fisher RI, Loh KK, Peterson BA, Phillips GL, Portlock CS, Rosenblum D, Armitage JO.
    Leuk Lymphoma; 1998 Dec; 32(1-2):139-49. PubMed ID: 10037009
    [Abstract] [Full Text] [Related]

  • 2. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
    Gale RP, Park RE, Dubois R, Bitran JD, Buzdar A, Hortobagyi G, Jones SE, Lazar GS, Spitzer G, Swain SM, Vaughn CB, Vogel CE, Martino S.
    Clin Transplant; 2000 Feb; 14(1):32-41. PubMed ID: 10693633
    [Abstract] [Full Text] [Related]

  • 3. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1998 Nov; 22(11):973-81. PubMed ID: 9783798
    [Abstract] [Full Text] [Related]

  • 4. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma.
    Gale RP, Park RE, Dubois RW, Anderson KC, Audeh WM, Bergsagel D, Jagannath S, Kyle RA, Oken MM, Perlman M, Rifkin RM, Stone MJ, Durie B.
    Leuk Lymphoma; 1999 May; 33(5-6):511-9. PubMed ID: 10342578
    [Abstract] [Full Text] [Related]

  • 5. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Sep; 23(9):817-26. PubMed ID: 10475621
    [Abstract] [Full Text] [Related]

  • 6. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Aug; 23(8):709-18. PubMed ID: 10456668
    [Abstract] [Full Text] [Related]

  • 7. [Autotransplantation in lymphomas: is it effective?].
    Surbone A, Armitage JO, Gale RP.
    Gematol Transfuziol; 1992 Aug; 37(7-8):3-6. PubMed ID: 1342984
    [Abstract] [Full Text] [Related]

  • 8. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
    Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM, Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee.
    J Clin Oncol; 2001 Jan 15; 19(2):406-13. PubMed ID: 11208832
    [Abstract] [Full Text] [Related]

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 10. Autotransplants in advanced non-Hodgkin lymphoma: are they effective?
    Surbone A, Armitage JO, Gale RP.
    Cell Transplant; 1992 May 15; 1(5):343-7. PubMed ID: 1344306
    [Abstract] [Full Text] [Related]

  • 11. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U.
    Lancet Oncol; 2017 Aug 15; 18(8):1076-1088. PubMed ID: 28668386
    [Abstract] [Full Text] [Related]

  • 12. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
    Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, Rodriguez J, Giralt S, Romaguera J, Rodriguez A, Preti A, Andersson B, Khouri I, Claxton D, de Lima M, Donato M, Anderlini P, Gajewski J, Cabanillas F, van Besien K.
    J Clin Oncol; 1998 Jan 15; 16(1):63-9. PubMed ID: 9440724
    [Abstract] [Full Text] [Related]

  • 13. Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
    Redondo AM, Pomares H, Vidal MJ, Pascual MJ, Quereda B, Sancho JM, Polo M, López J, Conde E, Jarque I, Alonso N, Ramírez MJ, Fernández P, Sayas MJ, Requena MJ, Salar A, González JD, González-Barca E, Arranz R, Caballero D, Martín A.
    Br J Haematol; 2014 Mar 15; 164(5):668-74. PubMed ID: 24274082
    [Abstract] [Full Text] [Related]

  • 14. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
    Hanley D, Gorelick PB, Elliott WJ, Broder MS, Saver JL, Kidwell CS, Fagan SC, Wilson A, Lennihan L, Schwer WA, Rubenstein LZ, Crowell RM, Haines SJ, Lopez CC, Zorowitz R, Dubois RW.
    J Stroke Cerebrovasc Dis; 2004 Mar 15; 13(5):196-207. PubMed ID: 17903976
    [Abstract] [Full Text] [Related]

  • 15. Autotransplants: now and in the future.
    Gale RP, Armitage JO, Dicke KA.
    Bone Marrow Transplant; 1991 Feb 15; 7(2):153-7. PubMed ID: 2049559
    [Abstract] [Full Text] [Related]

  • 16. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
    Vitolo U, Cortellazzo S, Liberati AM, Freilone R, Falda M, Bertini M, Botto B, Cinieri S, Levis A, Locatelli F, Lovisone E, Marmont F, Pizzuti M, Rossi A, Viero P, Barbui T, Grignani F, Resegotti L.
    J Clin Oncol; 1997 Feb 15; 15(2):491-8. PubMed ID: 9053470
    [Abstract] [Full Text] [Related]

  • 17. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
    Mounier N, Canals C, Gisselbrecht C, Cornelissen J, Foa R, Conde E, Maertens J, Attal M, Rambaldi A, Crawley C, Luan JJ, Brune M, Wittnebel S, Cook G, van Imhoff GW, Pfreundschuh M, Sureda A, Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT).
    Biol Blood Marrow Transplant; 2012 May 15; 18(5):788-93. PubMed ID: 22005647
    [Abstract] [Full Text] [Related]

  • 18. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A, Forman SJ.
    Semin Hematol; 2006 Oct 15; 43(4):240-50. PubMed ID: 17027658
    [Abstract] [Full Text] [Related]

  • 19. High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
    Vitolo U, Liberati AM, Cabras MG, Federico M, Angelucci E, Baldini L, Boccomini C, Brugiatelli M, Calvi R, Ciccone G, Genua A, Deliliers GL, Levis A, Parvis G, Pavone E, Salvi F, Sborgia M, Gallo E, Intergruppo Italiano Linfomi.
    Haematologica; 2005 Jun 15; 90(6):793-801. PubMed ID: 15951292
    [Abstract] [Full Text] [Related]

  • 20. [Role of high-dose chemotherapy and autologous blood stem cell transplantation in patients with diffuse large B-cell lymphoma].
    Gavrilina OA, Gabeeva NG, Morozova AK, Sidorova AA, Zvonkov EE.
    Ter Arkh; 2013 Jun 15; 85(7):90-7. PubMed ID: 24137955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.